English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory disease characterized by progressive airflow limitation due to small airway disease, parenchymal destruction, and abnormal inflammatory responses in the lung. The primary symptoms of COPD include dyspnea (i.e., breathlessness), cough, and augmented sputum production. COPD is considered one of the most prevalent and debilitating diseases among adults, as it is associated with high levels of morbidity and mortality and a marked deterioration in health-related quality of life (HRQOL). The most common risk factor for developing COPD is cigarette smoking. Although COPD is not presently curable, the prognosis has improved over the last decade due to advances in medical treatment. Despite improvements in prognosis, COPD continues to have deleterious effects on patients’ HRQOL due to medical and mental health comorbidities. Behavioral treatments can be a helpful adjunct in managing COPD and increasing HRQOL. The present article will discuss COPD’s impact on patients’ psychosocial functioning and describe behavioral treatments for managing COPD symptoms and increasing HRQOL.

Behavioral medicine treatment for patients with chronic obstructive pulmonary disease